Success Metrics

Clinical Success Rate
86.7%

Based on 13 completed trials

Completion Rate
87%(13/15)
Active Trials
1(5%)
Results Posted
38%(5 trials)
Terminated
2(9%)

Phase Distribution

Ph phase_4
9
41%
Ph phase_3
1
5%
Ph phase_2
6
27%
Ph not_applicable
3
14%
Ph phase_1
1
5%

Phase Distribution

1

Early Stage

6

Mid Stage

10

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
1(5.0%)
Phase 2Efficacy & side effects
6(30.0%)
Phase 3Large-scale testing
1(5.0%)
Phase 4Post-market surveillance
9(45.0%)
N/ANon-phased studies
3(15.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.5%

13 of 17 finished

Non-Completion Rate

23.5%

4 ended early

Currently Active

1

trials recruiting

Total Trials

22

all time

Status Distribution
Active(3)
Completed(13)
Terminated(4)
Other(2)

Detailed Status

Completed13
Withdrawn2
Not yet recruiting2
Terminated2
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
1
Success Rate
86.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (5.0%)
Phase 26 (30.0%)
Phase 31 (5.0%)
Phase 49 (45.0%)
N/A3 (15.0%)

Trials by Status

recruiting15%
withdrawn29%
completed1359%
not_yet_recruiting29%
terminated29%
unknown29%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT06739551Phase 2

Systemic Treatment Options for Generalized Lichen Planus

Not Yet Recruiting
NCT04537689Phase 4

Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis

Recruiting
NCT04239859Phase 4

Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis

Not Yet Recruiting
NCT05203354Phase 4

Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin

Completed
NCT04245319Not Applicable

Combined Effect of Acitretin and Narrow Band Ultraviolet B on Vitiligo Repigmentation

Unknown
NCT02181790Phase 4

Addition of Excimer Laser to Treatment With Acitretin Tablets for Psoriasis of the Palms and Soles

Terminated
NCT03753867Phase 1

RA Effect on Cell Surface Molecules in Vivo

Withdrawn
NCT00395941Phase 2

Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With Psoriasis

Completed
NCT02050321Phase 2

A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma

Terminated
NCT01078168Phase 2

Alzheimer's Disease Acitretin Medication

Completed
NCT02330380

Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation

Completed
NCT01812954

Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis

Completed
NCT00003611Not Applicable

Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation

Completed
NCT00156247Phase 2

Acitretin and Etanercept in Psoriasis

Completed
NCT01545284Phase 2

Pilot Study on the Use of Acitretin for the Treatment of Severe Chronic Hand Dermatitis

Completed
NCT01299220Phase 4

Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)

Withdrawn
NCT00936065Phase 4

Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

Completed
NCT01443338Phase 4

Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2

Unknown
NCT00644384Not Applicable

Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer

Completed
NCT01039142Phase 4

Dose Ranging Study to Assess the Efficacy and Safety of Acitretin in Severe Plaque Type Psoriasis

Completed

Drug Details

Intervention Type
DRUG
Total Trials
22